Faculty and Staff News
National leader tapped to chair Department of Neurological Surgery
IU School of Medicine and IU Health Physicians have recruited a nationally respected neurosurgeon to lead the Department of Neurological Surgery.
Shelly D. Timmons, MD, PhD, comes to Indiana from the Penn State Health Milton S. Hershey Medical Center, where she is vice chair for administration in the Department of Neurosurgery and director of neurotrauma. She holds leadership roles in several national societies and organizations and completed a term as president of the American Association of Neurological Surgeons on April 17.
She will be the first woman to lead the IU department and only the fourth woman to serve as chair of a neurosurgical department at a U.S. medical school.
“Dr. Timmons is an impressive leader who has excelled in all aspects of academic medicine: research, education and patient care,” said Jay L. Hess, MD, PhD, MHSA, dean of IU School of Medicine and IU’s executive vice president for university clinical affairs. “Under her leadership, our vision is to build on the department’s many strengths and to transform the way we care for patients with complex neurological injuries and illnesses.”
For more on Timmons’ appointment, visit the Newsroom.
White Coat Ceremony is next Friday
The IU School of Medicine Class of 2023 will celebrate an educational and professional milestone at the White Coat Ceremony, which will be held from 4:30-6:30 pm, Friday, August 2, at Hilbert Circle Theatre in downtown Indianapolis.
The ceremony marks a transformation for first-year students entering medical school. Professional attitudes and ethical behavior are critical attributes of all physicians in training. The short white coats worn by medical students elicit the high expectations patients have of the doctor-patient relationship.
This year’s incoming medical students will be joined by family and friends as they are officially welcomed into the IU School of Medicine community.
The White Coat Ceremony was established by the Arnold P. Gold Foundation in 1993. It is considered a “rite of passage” for first-year medical students.
First patient to try FDA-approved drug for amyloidosis is thankful
More than a decade has passed since Terry Baker first noticed signs of amyloidosis. Back in 2008, his toes tingled and felt swollen. He said it felt like he was walking on pins and needles. These symptoms were indicators that he could have the same genetic condition his mother had, so he set an appointment to meet with the doctor she had trusted, Merrill D. Benson, MD, professor of pathology and laboratory medicine at IU School of Medicine. Benson had been working on developing a treatment for amyloidosis, but it wasn’t ready to be tested in patients just yet.
“It was a huge relief just to know that he was in the process of developing a drug that he thought would help slow or possibly stop progression of the disease,” said Baker, who is 68 years old. “That was very reassuring, and I just kind of fell in love with Dr. Benson, as far as his personality and his approach to the whole thing.”
Amyloidosis is considered a rare disease, with fewer than 200,000 patients affected in the U.S. The condition occurs when amyloids, which are proteins, get folded abnormally and build up in a patient’s organs, causing them to begin to shut down. If left untreated, patients can die within a handful of years of showing symptoms.
“After seeing these patients and not having any specific therapy for them, other than treating their heart failure and their kidney failure, we decided perhaps a specific therapy would be a good thing,” Benson said.
Learn more about Benson’s drug therapy and Baker, who was the first patient enrolled in the final phase of the FDA trial, in this Rare Disease Research blog post. The trial was conducted by the Indiana Clinical and Translational Sciences Institute (CTSI).
August 6: Don’t miss a special event for IU Simon Cancer Center
IU School of Medicine faculty, staff and learners are invited to join in a milestone event for the Indiana University Melvin and Bren Simon Cancer Center. Doug Lowy, acting director of the National Cancer Institute, will make a special announcement about the future of the cancer center at 11 am, Tuesday, August 6. The event will be held in the Walther Hall Atrium, 980 W. Walnut St., in downtown Indianapolis.
Remarks will be offered by Michael A. McRobbie, president, Indiana University; IU School of Medicine Dean Jay L. Hess, MD, PhD, MHSA, executive vice president for university clinical affairs; Patrick J. Loehrer, MD, director, IU Simon Cancer Center; and Dennis Murphy, president and CEO, Indiana University Health.
Light refreshments will be served. Parking is available in Lockefield Garage, 951 Wishard Blvd. RSVPs are requested but not required.
Patient with rare condition thanks faculty for saving son
When Krista Verba went through her first two pregnancies, she experienced minimal complications. But when it came time for baby No. 3, things were different.
“We knew ahead of time that things would be a little bit rockier,” Verba said.
While pregnant with her second son, Hudson, Verba learned antibodies developed in her blood that could harm the baby. Her doctors recommended more frequent ultrasounds throughout the rest of her pregnancy and Hudson was monitored with a Middle Cerebral Artery (MCA) Doppler, which is a specialized scan to determine if there is fetal anemia. When Hudson was born, he spent a week in the neonatal intensive care unit, where he received intravenous immunoglobulin (IVIG) treatment, two blood transfusions and was under seven phototherapy lights. Thankfully, Hudson quickly outgrew his anemia, but making plans for the future became more difficult for the Verba family.
“The first baby is never affected, then after that, each baby gets worse and worse,” Verba said. “Some doctors said we shouldn’t have more kids. Others said you can, but it will be risky. We waited a couple of years, but my husband and I really wanted one more to add to our family.”
Verba was referred to the maternal fetal medicine division at Indiana University Health University Hospital. Learn more about the couple’s journey, including the expert care Verba received from IU School of Medicine physician Anthony Shanks, MD, in this Spirit of Medicine blog post.
Weekly INScope schedule resumes August 8
Summer is flying by, and that means INScope will soon resume weekly publication. Today’s issue is the last edition of the abbreviated summer publication schedule. Weekly distribution of INScope will resume Thursday, August 8.
Have some news to share with the school community? Email INScope submissions to email@example.com. The deadline for submissions is Wednesday at noon for each Thursday’s issue. For more information, visit the INScope page on MedNet.
June research awards total over $8.6 million
June 2019 Grant Awards Investigator Sponsor Type Project Title Begin Date End Date Awarded Dollars Gianfranco Alpini National Institute Of Diabetes, Digestive & Kidney New The Role of Stem Cell Derived Microvesicles in Cholestatic Liver Injury 6/1/2019 5/31/2020 $402,196 Tarah Jean Ballinger Conquer Cancer Foundation New Good vibrations: a novel mechanical intervention to understand and preserve musculoskeletal health in early stage breast cancer 7/1/2019 6/30/2022 $200,000 Caitlin Bernard Society Of Family Planning Renewal (not prev committed) Post-FFP Salary Support 7/1/2019 6/30/2020 $60,000 Sha Cao Grace M. Showalter Trust New Delineating the variational epigenetic regulation on gene expression conditional on cell fractions in cancer tissue and its implications on alternative drug resistance mechanisms 7/1/2019 6/30/2020 $60,000 Aaron E Carroll National Institute Of General Medical Sciences New Podcasts to Address the Impact of the Culture of Science on Reproducibility of Research 6/1/2019 5/31/2020 $132,121 Erica L Clinkenbeard Grace M. Showalter Trust New Investigating the mechanism of Zhx2 in MSC cell fate commitment 7/1/2019 6/30/2020 $60,000 Timothy W Corson Brightfocus Foundation New Inhibiting a novel target for wet AMD therapy 7/1/2019 6/30/2021 $200,000 Marsha DeSmet Grace M. Showalter Trust New The Role of Fibroblast Growth Factor Receptors In the Papillomavirus Replicative Lifecycle 7/1/2019 6/30/2020 $60,000 John M DeWitt Pennsylvania State University New CHARM 2: Chemotherapy for ablation and resolution of mucinous pancreatic cysts: a prospective, randomized, double-blind, multi-center clinical trial. 8/1/2018 7/31/2019 $111,855 Kenneth W. Dunn Nih Office Of The Director New Confocal/multiphoton microscope system for the Indiana Center for Biological Microscopy 6/3/2019 6/2/2020 $599,328 Peter J Embi Regenstrief Institute, Inc. Renewal (not prev committed) Regenstrief 44-825-70 7/1/2019 6/30/2020 $1,262,948 Carmella Evans-Molina University Of South Florida Renewal (not prev committed) Data Coordinating Center for Type 1 Diabetes TrialNet (UC4) UC4-3 3/1/2019 9/30/2019 $8,796 Carmella Evans-Molina National Institute Of Diabetes, Digestive & Kidney New Modeling Islet Dysfunction During Type 1 Diabetes Progression 7/1/2019 4/30/2020 $226,464 Sherif S Farag National Marrow Donor Program New Composite Health Assessment Model for Older Adults: Applying Pre-transplant Comorbidity, Geriatric Assessment, and Biomarkers to Predict Non-Relapse Mortality after Allogeneic Transplantation (CHARM)Composite Health Assessment Model for Older Adults: Appl 5/6/2019 5/6/2024 $35,310 Gregory W Faris Emergency Medicine Foundation New Utilizing Simulation to Improve Pediatric Prehospital Medical Care. 7/1/2019 6/30/2020 $3,750 Jamie Lynn Felton Grace M. Showalter Trust New Immunometabolism and the Islet Microenvironment in Type 1 Diabetes 7/1/2019 6/30/2020 $60,000 Monika Fischer University Of North Carolina At Chapel Hill New "Tofacitinib response in UC (TOUR) ¿ a real world prospective multicenter study" 6/4/2019 6/4/2021 $21,200 Tatiana M Foroud Parkinson's Disease Foundation New The Parkinson¿s Foundation Genetics Research Initiative 1/1/2019 4/30/2020 $351,633 J Dennis Fortenberry University Of Alabama Birmingham Renewal (not prev committed) STI Clinical Trials Group 9/15/2018 9/14/2019 $8,078 Shaun J Grannis University Of Colorado Denver New Incremental Privacy-Preserving Record Linkage (iPPRL) to Reduce Barriers to Data Sharing and Improve Data Quality 3/1/2019 2/29/2020 $19,333 David M Haas Rti International Renewal (not prev committed) Pregnancy as a Window to Future Cardiovascular Health 1/1/2019 12/31/2019 $48,222 Takashi Hato Grace M. Showalter Trust New Mechanisms of translation shutdown in bacterial sepsis 7/1/2019 6/30/2020 $60,000 Richard J. Holden National Institute On Aging New Brain Safe: Consumer Intervention to Reduce Exposure to Drugs Linked to Alzheimer's Disease 6/15/2019 2/29/2020 $771,262 Heather Ann Hundley National Science Foundation New RoL: NSF/MCB-BSF: RNA-mediated regulation of innate immunity 7/1/2019 6/30/2023 $838,303 Joseph Ipe Grace M. Showalter Trust New Improving Drug Penetration and Efficacy in Breast Cancer Metastases 7/1/2019 6/30/2020 $60,000 Xiaoming Jin Indiana State Department Of Health New Longitudinal imaging of cortical activity and neuroinflammation after mild traumatic brain injury 7/1/2019 6/30/2021 $160,000 Chandy C John Doris Duke Charitable Foundation, Inc New Prolonged use of hydroxyurea in children with sickle cell anemia in sub-Saharan Africa: the NOHARM Long-Term (LT) Study 9/1/2019 8/31/2024 $100,000 Stephen J. Jordan National Institute Allergy & Infectious Diseases New Role of Interferon-gamma in Clearance of Chlamydia trachomatis Infection in Women 6/21/2019 5/31/2020 $183,863 Mark H Kaplan National Heart, Lung And Blood Institute New IL-9-secreting tissue-resident memory T cells in allergic airway disease 6/1/2019 5/31/2020 $30,306 Mark H Kaplan National Institute Allergy & Infectious Diseases Renewal (not prev committed) Immunology and Infectious Diseases Training Program 8/1/2019 7/31/2020 $377,619 Jungsu Kim National Institute On Aging New The role of aging-associated microRNAs in Alzheimer's disease 7/1/2019 5/31/2020 $393,750 Kok Lim Kua Grace M. Showalter Trust New Novel Role of Reg3g in Pancreatic Islet Dysfunction of Offspring Born to Diabetic Mothers 7/1/2019 6/30/2020 $60,000 Charly Lai University Of Pittsburgh Renewal (not prev committed) A Phase II Trial for Metformin for Pulmonary Hypertension in Heart Failure with Preserved Ejection Fraction 7/1/2019 2/29/2020 $31,500 Benjamin John Landis National Marfan Foundation New Investigating the ubiquinone biosynthesis gene COQ8B in thoracic aortopathy 7/1/2019 6/30/2021 $75,000 Cristian Alberto Lasagna Reeves Indiana State Department Of Health New Astrocyte-derived tau oligomers in neurodegeneration associated to TBI 7/1/2019 6/30/2021 $160,000 Ping Li Grace M. Showalter Trust New A novel way to protect xenografts in xenotransplantation: Introducing HLA-G gene in pig genome 7/1/2019 6/30/2020 $60,000 Jianyun (Jean) Liu Grace M. Showalter Trust New Regulation of the antitumor activity of NKT cells by NF1 7/1/2019 6/30/2020 $50,000 Yan Liu Grace M. Showalter Trust New Showalter Scholar - Yan Liu 7/1/2019 6/30/2020 $25,000 Roberto F Machado Cleveland Clinic Foundation Renewal (not prev committed) Mechanisms of metabolic dysregulation in pulmonary hypertension 3/1/2019 2/28/2020 $179,125 Jean P Molleston Cystic Fibrosis Foundation New Cystic Fibrosis Foundation First & Second Year Clinic Fellowship 7/1/2019 6/30/2020 $61,750 Paula Monje Indiana State Department Of Health New Lithium therapy: a novel combinatorial strategy to boost Schwann cell-mediated spinal cord repair 7/1/2019 6/30/2021 $160,000 Amber L Mosley Grace M. Showalter Trust New Showalter Scholar - Amber Mosley 7/1/2019 6/30/2020 $25,000 Edward A Motea Grace M. Showalter Trust New Mechanistic studies for tumor-selective use of cMET inhibitors in cancers 7/1/2019 6/30/2020 $60,000 Harikrishna Nakshatri University Of Notre Dame New An Engineered Tissue Model of Aged Mammary Microenvironment 5/1/2019 1/31/2020 $44,001 Kwangsik Nho University Of Utah New Integrative Analysis of Alternative Splicing in Alzheimer¿s Disease 5/1/2019 2/29/2020 $78,750 Heather Ann O'Leary Grace M. Showalter Trust New Non-Physiologic Oxygen Tensions Inappropriately Bias Biological and Pre-clinical Studies;Creating an Environment to Understand Biology and Disease 7/1/2019 6/30/2020 $60,000 Ruchi Pandey Grace M. Showalter Trust New Targeting protein tyrosine phosphatase, SHP2 in a mouse model of acute myeloid leukemia 7/1/2019 6/30/2020 $60,000 Rupa Radhakrishnan American Society Of Pediatric Neuroradiology New Effect of Pre-eclamptic Milieu on Neonatal Brain Perfusion, Growth and Function 7/1/2019 6/30/2020 $27,500 Christopher Michael Robinson Grace M. Showalter Trust New Bacterial enhancement of Coxsackievirus stability 7/1/2019 6/30/2020 $60,000 Sashwati Roy Applied Technologies International New Electroceutical technology against bacterial drug resistance 3/19/2019 3/21/2020 $200,000 Konrad M Szymanski National Institute Of Diabetes, Digestive & Kidney New A patient-centered approach to urinary incontinence and quality of life in children and adolescents with spina bifida 6/1/2019 3/31/2020 $170,388 Kenneth E. White National Institute Of Diabetes, Digestive & Kidney New Therapeutic potential of HIF-PHDi in the control of bioactive FGF23 in CKD. 8/1/2019 7/31/2020 $32,024 Aruna B Wijeratne Grace M. Showalter Trust New Cellular Thermal Shift Assay (CETSA) on ATPases: Method Development and Application to Study Protein Stability Changes of Hepatocytes due to ER-Stress induced by Thapsigargin 7/1/2019 6/30/2020 $60,000
Findings from CARE Consortium added to global repository for brain injury data
Data from the world’s most comprehensive concussion study is now publicly available in a repository aimed at providing traumatic brain injury researchers access to a wealth of new knowledge.
The U.S. Department of Defense announced recently that data from the NCAA-DoD Concussion Assessment, Research and Education (CARE) Consortium is now available through the Federal Interagency Traumatic Brain Injury Research (FITBIR) informatics system.
Developed by the National Institutes of Health and the Department of Defense, the goal of the FITBIR informatics system is to help share data across the entire traumatic brain injury research field, and to make collaboration between laboratories easier than before.
With this addition, data from the CARE Consortium comprises nearly two-thirds of the entire FITBIR informatics system.
“An unprecedented amount of data on the short-term effects of concussions has been compiled through the CARE Consortium. Now that knowledge is easily accessible by investigators from around the world,” said Thomas McAllister, MD, chair of the Department of Psychiatry at IU School of Medicine and the leader of the study’s administrative operations center. “All of these findings can help researchers start to answer important questions about concussion, and continue to grow the footprint of the CARE Consortium on advancing concussion science.”
Read more details about the consortium’s findings in the Newsroom.
$1.8 million NIH grant funds researcher’s work on mobile compression device
Jason Watters, MD, assistant professor of clinical orthopaedic surgery, is partnering with an Indiana medical technology company to test the effectiveness of a mobile compression device in preventing deep vein thrombosis—a risky post-surgery side effect of a knee replacement.
Watters was one of two physicians chosen to participate in the study, which clinically tests the lightweight, quiet and wireless equipment developed by the Fishers-based Recovery Force, LLC.
Recovery Force’s Mobile Active Compressions (MAC) calf device has been in development since the company was founded five years ago. Now, a $1.8 million grant from the National Institutes of Health will cover the cost of testing the device on some 300 patients in Indianapolis and Boston over the next two years.
Watters will provide the MAC device to his knee replacement patients at Sidney & Lois Eskenazi Hospital, where more than 400 joint-replacement surgeries take place each year. More than 60 percent of those are knee replacements, Watters said.
Similar work for the study will take place at Tufts Medical Center in Boston. For more, read the Research Updates blog post.
Novel app designed to help patients avoid drugs linked to dementia
A team of researchers from IU School of Medicine, Regenstrief Institute and Purdue University, led by Richard Holden, PhD, is testing a new app, called Brain Safe, designed to help people reduce their exposure to a common class of drugs linked to Alzheimer’s disease. The National Institute on Aging is funding the $3.5 million, five-year study to evaluate the app’s effectiveness.
The Brain Safe app was created and designed by Holden and his team, and the app can be used on smartphones, tablets or computers. Designed to be used by older adults who take anticholinergics, its goal is to make people more aware, informed and empowered to initiate a conversation with their doctor about replacing these medications. The app includes a personalized risk calculator, targeted multimedia content and a conversation starter to help patients bring up the subject with a clinician.
The class of drug, called anticholinergics, has been linked to cognitive impairment, Alzheimer’s disease and dementia. These drugs include medications used to treat conditions such as heart failure and depression, some sleeping pills, allergy medicines and more, and can be prescription or over-the-counter. One in three older adults is prescribed one of these medications but may not be aware of the possible risks.
For more on the Brain Safe study, visit the Newsroom.
Faculty and Staff News
Elkas will assume new role at Riley Children’s Foundation
Elizabeth A. Elkas, the longtime leader of the Office of Gift Development, will depart IU School of Medicine in mid-August to assume the role of president and chief executive officer of Riley Children’s Foundation.
A reception to honor her will be held from 4:30 to 6:30 pm on Thursday, August 15 in the Fairbanks Hall Lobby.
Elkas joined IU School of Medicine in 1987 as one of the initial members of the school’s fundraising team. She was named associate dean for development in 2005 and was later promoted to a senior associate dean.
“Liz has been an invaluable member of the school community and an exceptional ambassador of our mission,” said Dean Jay L. Hess, MD, PhD, MHSA. “Under her leadership, the Office of Gift Development has been extraordinarily successful and raised vital funds for faculty endowments, student scholarships and research support.
“While Liz leaves big shoes to fill, we are fortunate that our fundraising team includes many talented professionals with long tenures and meaningful relationships with donors,” Hess added. “As a result, I am confident alumni, patient families and other donors will continue to feel inspired to give generously to our work.”
Hess appointed Michelle Petty, the executive associate director of development services who has worked closely with Elkas for more than 30 years, as interim chief of development. The school will launch a search for the next development leader in the near future.
Faculty preceptors needed in Indianapolis for FCP2 roles
Preceptors are urgently needed for Foundations of Clinical Practice Year Two (FCP 2) in Indianapolis for the 2019-20 academic year. Longitudinal preceptors will host up to two second-year learners in their clinic for a total of four afternoon visits between late August and December, with each session lasting three hours, on Monday, Tuesday, Wednesday or Thursday.
There are still opportunities for small group master clinicians and co-instructors as well. With an estimated time commitment of approximately four hours per week in the afternoons for 16 weeks, master clinicians and co-instructors lead students through small group sessions on case presentations, development of the differential diagnosis and the assessment and plan, and will grade approximately eight to 10 write-ups or exams per student per semester while observing students’ practice in class.
Full descriptions of the roles and required qualifications are outlined on the Teaching Opportunities in Medical Education site. Faculty are encouraged to explore these opportunities and register their interest for the timeframes that best suit their schedules. Questions? Contact Laurie Cline at firstname.lastname@example.org or Tamika Dawson, MD, at tdawson1@IUHealth.org.
Plan now for fall promotion and tenure events and office hours
Promotion and tenure events and office hours provide faculty members an opportunity to receive feedback and advice about the promotion and tenure process, including review of their materials. Most events are available remotely via Zoom.
- General overview: Tuesday, October 22
- Personal statement: Tuesday, October 29
- Documenting your work: Wednesday, October 30
- Preparing your CV: Thursday, November 7
- Department administration and staff: Tuesday, November 12
- Advancing to full professor: Wednesday, November 13
Nominations accepted year-round for Exemplar of Professionalism Honor Roll
The IU School of Medicine Exemplar of Professionalism Honor Roll recognizes faculty, residents, fellows, students and staff members who embody the school’s core values of excellence, respect, integrity, diversity and cooperation. The award celebrates positive role models who uphold the IU School of Medicine Honor Code in their daily interactions.
Nominations are accepted throughout the year. More details, including the list of past honor roll award recipients, are available.
Department of Family Medicine Run & Fun Walk is November 2; register by July 31 for early bird rate
As part of its 45th anniversary celebration, the IU School of Medicine Department of Family Medicine will host its inaugural Medical Miles 5K Run & Fun Walk from 9-11 am on Saturday, November 2. The event will take place at the Indianapolis downtown canal. A portion of the proceeds will support the medical student outreach clinic affiliated with the Department of Family Medicine.
Register your place on the starting line by Wednesday, July 31, to take advantage of the early bird rate.
Apply by September 7 for ICBI Technology Advancement Award
The Indiana Center for Biomedical Innovation (ICBI) Technology Enhancement Award (TEA) supports development of health care product-focused technologies with a goal of advancing toward commercialization. The critical preclinical data generated using the TEA award may support Small Business Innovation Research (SBIR)/Small Business Technology Transfer (STTR) application and engagement of a commercial partner. The technology may already reside in a start-up company, or a clear plan may exist to place it into a startup.
Applicants must be researchers (including postdoctoral fellows) within IU School of Medicine. More details and application information are available.
Mark Brothers Award lecture to be held September 10
Amy Shiu Lee, PhD, recipient of the Mark Brothers Award, will present "Critical role of the unfolded protein response regulator GRP78/BiP in cancer” at 3 pm, Tuesday, September 10, in Walther Hall (R3), Room 203.
Lee is the associate director for basic research and professor of biochemistry and molecular medicine at the University of Southern California Norris Comprehensive Cancer Center. Her research focuses on the mammalian stress response and molecular chaperones. Lee’s lab has made numerous discoveries in understanding how these genes are regulated and their role in the development of human diseases.
The Mark Brothers Award was established in 1997 in honor of Dr. Guey C. Mark's older brothers who emigrated from Canton, China. They settled in South Bend, Indiana, where they built a successful restaurant business. Due to their reverence and respect for higher education, Mark’s brothers supported his pursuit of a career in medicine.
Registration is available for the lecture and a reception immediately following.
Mark your calendar for fall Culture and Conversation events
Culture and Conversation is a monthly lunch discussion series for IU School of Medicine students, faculty and staff to engage in conversations about current events and cultural issues. Topics include representational diversity, inclusive working and learning environments, and cultural competence. Plan to attend these upcoming events:
Hickman named director of the Center for Aging Research
Susan Hickman, PhD, has been selected to lead the Indiana University Center for Aging Research at the Regenstrief Institute. She will be the second director in the center’s history.
Hickman is a clinical geropsychologist focused on optimizing the quality of life for older adults through improved decision-making and communication about treatment preferences. Much of her work is in advance care planning, helping people make decisions about the care they receive when they are not able to speak for themselves.
“Dr. Hickman’s tireless work on ways to protect patients’ wishes for their end-of-life care has transformed care and made a difference in countless lives. That dedication and her exceptional track record of research accomplishment make her an ideal leader for the Center for Aging Research,” said Peter Embi, MD, president and chief executive officer of Regenstrief Institute. “She will help lead our talented faculty in work that improves the lives of older adults.”
Read the full news release for more on Hickman’s appointment. The Center for Aging Research is a collaborative effort between IU School of Medicine and Regenstrief Institute.